SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike stock is hitting decade-long lows amid widespread negative sentiment, driven by a weak revenue outlook from competitors and ongoing skepticism regarding the company's internal turnaround strategy. Community discussions are deeply polarized between bargain hunters betting on a generational bottom supported by a four-percent dividend yield and bearish traders who argue the brand has lost its market relevance and leadership.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology is facing heightened volatility and intense debate among investors as the market anticipates the upcoming earnings report, with community sentiment sharply divided between those monitoring the potential for a short squeeze due to high short interest and those expressing frustration over management transparency and recent financing activities. Investors are closely tracking milestones related to data center expansion and GPU deployment, which many see as the critical catalysts that will either justify the company's valuation or validate concerns regarding dilution.

Duos Technologies Group, Inc. designs, develops, deploys, and operates intelligent technology solutions supporting rail, logistics, intermodal and government customers that streamlines operations, improves safety and reduces costs. It offers imaging, safety and security, software, and services. The firm also provides cutting edge solutions that automate the mechanical and security inspection of fast moving trains, trucks and automobiles through a broad range of proprietary hardware, software, information technology and artificial intelligence. The company was founded on May 31, 1994 and is headquartered in Jacksonville, FL.

Duos Technologies Group Inc

Duos Technologies is capturing market attention as it shifts toward edge data center infrastructure, highlighted by a significant five-year hosting agreement with Axe Compute valued at over $500 million. The community is actively debating the company's growth trajectory and aggressive infrastructure buildout, weighing the potential for a major valuation re-rate against concerns regarding execution risks and the need for future capital.

Fabrinet engages in the provision of optical packaging and electronic manufacturing services to original equipment manufacturers. The firm's engineering services include process design, failure analysis, reliability testing, tooling design, and real-time traceability system. Its manufacturing operations offer sensors, subsystems, customized optics, and optical modules and components. The company was founded by David Thomas Mitchell on August 12, 1999 and is headquartered in George Town, Cayman Islands.

Fabrinet

Fabrinet is experiencing high volatility as investors weigh robust quarterly earnings and record revenue growth against concerns over tepid near-term guidance and margin pressure. The community is actively debating the company's valuation and the potential for a technical correction, with many traders closely monitoring institutional activity and AI infrastructure demand as key indicators for its next move.

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Lululemon Athletica Inc

Lululemon is trending amid intense community debate over its turnaround prospects, with investors weighing the company's attractive valuation against concerns regarding brand fatigue and management transitions. While some market participants view the current price as a generational buying opportunity bolstered by institutional support, others remain skeptical about the retail sector's resilience and the company's ability to compete in a shifting consumer landscape.

Klarna Group Plc is a global digital bank and flexible payments provider. It operates through an AI-powered payments and commerce network that empowers people to pay smarter, with a mission to be available everywhere, for everything. The company was founded by Gustav Erik Niklas Adalberth, Karl Anders Victor Jacobsson, and Sebastian Marcin Siemiatkowski in 2005 and is headquartered in London, the United Kingdom.

Klarna Group plc

Klarna is trending as investors weigh significant upside potential from a pending antitrust lawsuit verdict against Google and a newly launched device-leasing partnership with Apple. While the community remains optimistic about the company's long-term growth and its potential to act as a financial super app, the stock continues to see high volatility as traders react to pre-earnings sentiment and mixed flow data.

Aehr Test Systems engages in the design, manufacture, market, and sale of test and burn-in equipment used in the semiconductor industry. Its products include FOX-XP, FOX-NP, and FOX-CP wafer contact parallel test and burn-in systems, the WaferPak full wafer contactor, the DiePak Carrier, the WaferPak Aligner, the DiePak Autoloader, and test fixtures. The company was founded by Rhea J. Posedel on May 25, 1977 and is headquartered in Fremont, CA.

Aehr Test Systems

Aehr Test Systems is seeing heavy volatility as investors debate whether the stock's recent sharp rally is driven by strong backlog demand in AI infrastructure or if it has become an overextended play prone to insider selling and potential dilution. The community remains sharply divided, with bulls pointing to the company's monopoly on wafer-level burn-in as a critical AI bottleneck, while bears are aggressively shorting the name based on high valuation multiples and recent insider share divestments.

Aurora Innovation, Inc. engages in the design and development of automobile hardware, software, and provision of data services. It offers the Aurora Driver which allows a vehicle to drive itself. The company was founded by Christopher Urmson, Sterling Anderson and James Andrew Bagnell in 2017 and is headquartered in Pittsburgh, PA.

Aurora Innovation Inc - Ordinary Shares - Class A

Aurora Innovation is trending as investors react to the launch of its second-generation driverless truck fleet, with the community closely tracking the company's commercial scaling milestones and upcoming earnings report. Discussions focus on whether this hardware progression will act as a catalyst to overcome recent price stagnation and drive the transition toward widespread autonomous freight deployment.

Amylyx Pharmaceuticals, Inc. is a biotechnology company focused on the discovery and development of therapies for diseases with significant unmet medical need, with an emphasis on endocrine and neurodegenerative disorders. Its program, avexitide, is a once-daily GLP-1 receptor antagonist being developed for the treatment of post-bariatric hypoglycemia. Amylyx’s pipeline also includes investigational programs targeting Wolfram syndrome and amyotrophic lateral sclerosis (ALS). The company was founded by Joshua Cohen and Justin Klee in 2013 and is headquartered in Cambridge, MA.

Amylyx Pharmaceuticals Inc

Amylyx Pharmaceuticals is capturing significant investor attention as the community tracks the upcoming Phase 3 LUCIDITY trial results for avexitide in post-bariatric hypoglycemia, with many citing a strong cash runway into 2028 and a potential first-in-class market opportunity. Investors are actively discussing the stock's long-term potential in orphan diseases and speculating on M&A interest, while technical traders and community members monitor short interest and institutional accumulation patterns.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is trending as investors focus on the company's upcoming Q4 Biologics License Application for its prostate cancer therapy, which the community views as a de-risked asset with significant market potential. The conversation is further fueled by strong institutional interest, including reports of increased stake-building, and anticipation surrounding the company's presentation at the Canaccord Genuity Growth Conference.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$SGMO Still, Roche needs to win the objection, to clear the path for shareholder representatives filing for their right for the future payments asset(or at the very least that the value of the asset is recognized). A new Merope auction would be very likely as well. 
Not really sure if the two other objections can force the same thing.(but interesting) 
The court date is 20th of August, 10 am, I believe.

JimiJo Jeeter

Ronald Baker

Charles ford

StockTwits Web

Sangamo Therapeutics Inc

 Still, Roche needs to win the objection, to clear the path for shareholder representatives filing for their right for the future payments asset(or at the very least that the value of the asset is recognized). A new Merope auction would be very likely as well. 
Not really sure if the two other objections can force the same thing.(but interesting) 
The court date is 20th of August, 10 am, I believe.

Kenn Jannsen

@Polymorpher These assets are worth a lot more, IMVHO. I could live with another auction that nets $100 million or more.....

Squeaky Toy

Stiv Bators

StockTwits For Android 

 These assets are worth a lot more, IMVHO. I could live with another auction that nets $100 million or more.....

@Polymorpher Yeah I doubt it happens courts usually do not like to reverse things without overwhelming evidence. I guess we shall see.

Apostle Kolocotronis

 Yeah I doubt it happens courts usually do not like to reverse things without overwhelming evidence. I guess we shall see.

Pete Sidders

@Patrick2343 Assets have been bargained for and purchased, a signed contract, therefor also pre-auction settled ownership and furthermore an active use of said ownership/rights, would all be considered about as strong evidence as You can possibly get. 
You would need very strong evidence against these points to claim to have any sort of case to nullify it. Or I&#39;d expect a massive influx of lawsuits following such a ruling.  
I mean, You could basically sell ownership to such asset and let that alone prove it&#39;s considered to have worth and even let other companies prove assets have worth through R&amp;D,  active use etc., then just nulify all the contracts and ownerships and walk away with the money🤷 
(and as attempted in this case, even use that to nulify shareholder rights and value..)

 Assets have been bargained for and purchased, a signed contract, therefor also pre-auction settled ownership and furthermore an active use of said ownership/rights, would all be considered about as strong evidence as You can possibly get. 
You would need very strong evidence against these points to claim to have any sort of case to nullify it. Or I'd expect a massive influx of lawsuits following such a ruling.  
I mean, You could basically sell ownership to such asset and let that alone prove it's considered to have worth and even let other companies prove assets have worth through R&D,  active use etc., then just nulify all the contracts and ownerships and walk away with the money🤷 
(and as attempted in this case, even use that to nulify shareholder rights and value..)

@Polymorpher @Patrick2343 
&quot;The Producers&quot; come to mind ....
Bialystock and Bloom selling 50% rights to countless widows....lol

 
"The Producers" come to mind ....
Bialystock and Bloom selling 50% rights to countless widows....lol

@Polymorpher 

What the Equity Committee needs is the exact opposite: They need the judge to either overrule Roche (cleansing the asset under Section 363) OR they need to prove that the threat of these unresolved IP issues caused &#39;chilled bidding&#39; from the start. That is the legal trigger required to force a new, unencumbered auction and unlock the true value.

StockTwits for iOS

 

What the Equity Committee needs is the exact opposite: They need the judge to either overrule Roche (cleansing the asset under Section 363) OR they need to prove that the threat of these unresolved IP issues caused 'chilled bidding' from the start. That is the legal trigger required to force a new, unencumbered auction and unlock the true value.